Table 2.
Characteristics of all patients participating in the item selection interviews (n=25).
| Patient characteristics | Values | ||||
| Gender, n (%) | |||||
|
|
Female | 13 (48) | |||
|
|
Male | 12 (52) | |||
| Age (years), mean (SD; range) | 66 (8; 55-79) | ||||
| Lung cancer stage, n (%) | |||||
|
|
Stage I | 2 (8) | |||
|
|
Stage II | 3 (12) | |||
|
|
Stage III | 9 (36) | |||
|
|
Stage IV | 11 (44) | |||
| Treatment modality, n (%) | |||||
|
|
Surgery | 5 (20) | |||
|
|
|
Radiotherapy | 3 (12) | ||
|
|
|
Stereotactic radiotherapy | 2 (8) | ||
|
|
Concurrent chemoradiation | 5 (20) | |||
|
|
Systemic treatments | ||||
|
|
|
Chemotherapy | 1 (4) | ||
|
|
|
Immunotherapy | 6 (24) | ||
|
|
|
Targeted therapy | 3 (12) | ||
| Treatment status, n (%) | |||||
|
|
On treatment | 14 (56) | |||
|
|
<1 month posttreatment | 9 (36) | |||
|
|
1-3 months posttreatment | 2 (8) | |||
| Highest level of education, n (%) | |||||
|
|
Primary school | 3 (12) | |||
|
|
Lower vocational education | 2 (8) | |||
|
|
High school | 9 (36) | |||
|
|
Higher vocational education | 6 (24) | |||
|
|
Scientific education | 5 (20) | |||